Cargando…
pH-dependent structural characteristics of lonidamine: (1)H and (13)C NMR study
Lonidamine (LND) is an anti-cancer drug with great potential as a metabolic modulator of chemotherapy, radiotherapy, hyperthermia, and photodynamic therapy in cancer treatment. LND affects several important aspects of cancer cell metabolism: it inhibits Complex I and II of the electron transport cha...
Autores principales: | Gupta, Pradeep Kumar, Orlovskiy, Stepan, Roman, Jeffrey, Pickup, Stephen, Nelson, David S., Glickson, Jerry D., Nath, Kavindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316351/ https://www.ncbi.nlm.nih.gov/pubmed/37404315 http://dx.doi.org/10.1039/d3ra01615c |
Ejemplares similares
-
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
por: Nath, Kavindra, et al.
Publicado: (2018) -
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016) -
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice
por: Nath, Kavindra, et al.
Publicado: (2016) -
Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance
por: Chen, Enping, et al.
Publicado: (2021) -
(1)H-NMR and (13)C-NMR dataset for some oxidative metabolites of CRA13 and their analogs
por: Hassan, Ahmed H.E., et al.
Publicado: (2018)